Januvia

Diabetes drugs under scrutiny

Diabetes drugs under scrutiny

By

Diabetes medications Januvia and Byetta significantly increase the risk of pancreatic inflammation, according to Johns Hopkins University School of Medicine researchers.

Diabetes drugs linked to pancreatitis have a possible cancer connection, FDA says

By

The Food and Drug Administration is investigating a possible link between commonly prescribed diabetes drugs and pancreatic cancer. The drugs, including Januvia and Byetta, were previously connected with fatal cases of pancreatic inflammation known as pancreatitis.

Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find

By

Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who did not take a prescription drug to treat the condition during that period.